CX3CL1 and periodontitis: Regarding pharmacological agents targeting the CX3CL1/CX3CR1 axis in the pathogenesis of periodontitis, it has been shown that the therapeutic CX3CR1 antagonist called “F1” was able to inhibit leukocyte recruitment in a murine model of thioglycolate‐induce periodontitis.54, 55